Bacopa (Brahmi) in Ayurveda

What it is and how Ayurveda describes it

A name that points to two plants. "Brahmi" in Ayurvedic practice corresponds to two different plants, Bacopa monnieri and Centella asiatica. [6] The second plant is called mandukaparni in Ayurvedic texts and trials [7] and gotu kola in English. [8] A bottle labeled "brahmi" may therefore contain either one, and they have different evidence and safety profiles. See gotu kola (mandukaparni). Check the Latin name on a label.

What research has measured

1. Overall cognition in adults

   Promising but limited

   A 2014 meta-analysis of 9 randomized trials (518 people) [10] found a possible improvement in cognition, particularly speed of attention. [11] The authors said only a large, well-designed head-to-head trial against an existing medication would give definitive data. [12]

2. Memory

   Promising but limited

   A 2012 systematic review of 6 trials, all 12 weeks long, found improved performance on 9 of 17 tests of memory free recall. [13] [14] It found little evidence of benefit in other thinking skills. [15]

3. Healthy adults, compared with ginkgo

   Promising but limited

   A 2026 network meta-analysis of 29 trials (2,107 people) [16] said bacopa shows promise as a cognitive enhancer, but found no significant differences in sustained attention, selective attention or processing speed, and noted the lack of direct comparisons. [17] [18] [19]

4. Children and teens

   Insufficient evidence

   A 2016 review of 5 studies reported benefits for some memory and attention measures, mild side effects in 2.3% of participants, and called for replicated, rigorous studies. [20] [21] [22]

5. Dementia or mild cognitive impairment

   Insufficient evidence

   The reviewers said a trial in healthy or dementia patients using a standardized preparation is still needed. [12]

The reviews show benefit on some tests and not others, which is why the label is "promising but limited" and not "established". Results came from specific extracts, so they may not apply to other products.

A trial that compared two herbs with each other. A 2025 trial in India randomized 180 healthy boys aged 8 to 10 to brahmi (Bacopa) or mandukaparni (Centella). [23] [24] It had no placebo group, so it cannot show that either herb works, and its subgroup results by prakriti (a traditional constitution type) cannot show that prakriti matters. [25] Single trials like this cannot settle the question, so this page relies mainly on systematic reviews.

Where this fits